Atlas Trials

Safety and Pharmacokinetics of FBR-002 for the Treatment of Patients Hospitalized With COVID-19 in Need of Supplemental Oxygen and at Risk of Severe Outcome

Clinical trial NCT05279352 · UNKNOWN

Trial details

NCT number
NCT05279352
Sponsor
Fab'entech
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2022-03-21
Primary completion
2022-06-15
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.